
Sign up to save your podcasts
Or


Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
By JAMA Network4.3
1818 ratings
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial

138 Listeners

322 Listeners

702 Listeners

498 Listeners

163 Listeners

288 Listeners

262 Listeners

3,339 Listeners

38 Listeners

21 Listeners

13 Listeners

11 Listeners

8 Listeners

16 Listeners

5 Listeners

6 Listeners

27 Listeners

1,154 Listeners

30 Listeners

192 Listeners

9 Listeners

88 Listeners

14 Listeners

5 Listeners

513 Listeners

5 Listeners

369 Listeners

249 Listeners

106 Listeners

19 Listeners

372 Listeners

3 Listeners